SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package and International Package. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as traders debate the company's outlook ahead of its upcoming earnings report, with sentiment divided between those expecting a turnaround driven by dividend yield and cost-cutting efforts and those bearish due to competition from Amazon and high labor costs.

Anthropic

Anthropic is trending due to widespread discussions surrounding its upcoming IPO and a series of high-profile infrastructure deals aimed at scaling its Claude AI models. While the community is divided over the company's valuation, recent product launches, and the potential impact of its agentic AI tools on existing software companies, enthusiasm for the public offering remains a dominant theme.

OpenAI

OpenAI is trending as the community debates potential IPO timelines for 2027 or sooner, with significant discussion surrounding the company's aggressive infrastructure investments and competition with rival AI labs. Traders are also actively monitoring the company's recent security incidents, management turnover, and ongoing legal disputes.

Direxion Shares ETF Trust - Direxion Daily Junior Gold Miners Index Bull 2X ETF

JNUG is trending as traders analyze the impact of high government debt and persistent inflation, while debate continues over the potential for gold and junior miners to act as safe-haven hedges against fiat currency debasement and geopolitical uncertainty. The conversation is fragmented, with community members heavily focused on macroeconomic indicators like rising Treasury yields and the government deficit rather than specific company news.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is currently trending due to community anticipation surrounding the recent launch of its SuperApp and ongoing discussions about enterprise adoption, specifically payroll integration and payment volume. Traders remain divided, with many expressing frustration over stagnant price action and criticizing the token as a "scam" or "stale," while others maintain a long-term bullish stance based on projected institutional use, upcoming legislative clarity, and consistent buyback activity.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is focused on the rapid and significant collapse of the meme coin, with many traders labeling the event a "rug pull" that resulted in heavy losses for investors. Discussion remains highly polarized, ranging from cynical mockery of the project's legitimacy to debates over the role of political figures in the cryptocurrency space.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending amid optimism regarding institutional adoption, growing real-world asset (RWA) integration on the XRP Ledger, and ongoing discussions surrounding potential regulatory developments such as the Clarity Act. Traders remain divided, however, as some point to positive inflows and infrastructure growth, while others express frustration over price action and ongoing concerns about potential supply dilution.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm shares are trending following a multi-generational partnership with Amazon Web Services to develop custom AI data center chips and optical connectivity, a deal valued at up to $60 billion. Investors are debating whether this catalyst successfully shifts the narrative beyond the shrinking handset business, with reactions split between enthusiasm for the long-term AI infrastructure pivot and skepticism regarding the stock's recent performance.

Direxion Shares ETF Trust - Direxion Daily MU Bull 2X ETF

Direxion Daily MU Bull 2X Shares

MUU is trending as traders analyze its price action and leverage mechanics in relation to Micron Technology's market performance. The community remains divided, with some investors utilizing the leveraged ETF for short-term scalping and others holding long-term positions based on bullish projections for the memory sector.

Volatility Shares Trust - 2x Bitcoin ETF

Volatility Shares 2x Bitcoin Strategy ETF

The discussion is primarily focused on price action and leverage strategies as traders debate whether Bitcoin's recent volatility signals a continuation of a bull cycle or an upcoming correction. Sentiment is divided between bulls targeting higher price levels and bears expressing concern over leverage decay and potential downside, with frequent mentions of monthly dividends and technical chart patterns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Sarepta Therapeutics (SRPT) Up 37% Since Last Earnings Report?

Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Pacira (PCRX) Up 6.9% Since Last Earnings Report: Can It Continue?

Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Pacira Q2 Earnings & Revenues Beat, 2026 Sales Outlook Cut

PCRX beats Q2 earnings estimates as higher product sales boost revenues, with Exparel demand and portfolio momentum supporting growth despite a guidance cut.

Pacira (PCRX) Tops Q2 Earnings and Revenue Estimates

Pacira (PCRX) delivered earnings and revenue surprises of +14.06% and +1.01%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare

Pacira gains a reimbursement boost as UnitedHealthcare separately covers Exparel in outpatient care, expanding access to non-opioid postsurgical pain treatment.

Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal

PCRX is set to sell its iovera franchise to ZBH in a deal worth up to $140M as it sharpens focus on biopharmaceutical growth.

Pacira To Sell Iovera Business To Zimmer Biomet; Pacira Shares Up

(RTTNews) - Pacira BioSciences Inc. (PCRX) on Tuesday announced an agreement to divest its iovera business to Zimmer Biomet Holdings (ZBH) for up to $140 million...

Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting

Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting PR Newswire BRISBANE, Calif., June 9, 2026 BRISBANE, Calif...

Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting

Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of...

Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees

Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees PR Newswire BRISBANE...

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Brisbane, CA.

Pacira BioSciences Inc

Pacira Biosciences Stock Rises On Multiple Price Target Upgrades: Retail Sentiment Soars

Equity

Neutral Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$25.36
Prev Close	$25.16
Open	$25.43
Dividend Yield	0.00%
50-Day Moving Average	$25.46
Beta	0.33
Avg. Volume	665,530.03
PE Ratio	73.08

52-Week High	$27.66
52-Week Low	$18.80
Market Capitalization	$1.01B
EPS (Annual)	$0.1562
Price to Book	1.50
Revenue Per Employee	$876,249.70

Feed

News

Sentiment

Earnings

Fundamentals

Info

PCRX Fundamentals